Ticker
AUPHCompany Name
AURINIA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 502.56M | $ 81.83M | 16.28% |
3/31/2025 | $ 504.85M | $ 77.91M | 15.43% |
12/31/2024 | $ 550.64M | $ 79.37M | 14.41% |
9/30/2024 | $ 549.36M | $ 87.85M | 15.99% |
6/30/2024 | $ 523.53M | $ 85.98M | 16.42% |
3/31/2024 | $ 516.63M | $ 88.54M | 17.14% |
12/31/2023 | $ 548.06M | $ 97.61M | 17.81% |
9/30/2023 | $ 555.01M | $ 93.21M | 16.79% |
6/30/2023 | $ 548.9M | $ 101.21M | 18.44% |
3/31/2023 | $ 451.76M | $ 7.93M | 1.76% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for AURINIA PHARMACEUTICALS INC is calculated as follows: Debt [ $ 8.3M ] / Assets [ $ 461.75M ]
(=) Debt to Assets [ 1.8% ]
Minimum
Dec 31, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |